Raia Drogasil S.A.
RADLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $11 | $11 | $10 | $10 |
| % Growth | 4% | 7.8% | -0.4% | – |
| Cost of Goods Sold | $8 | $8 | $7 | $7 |
| Gross Profit | $3 | $3 | $3 | $3 |
| % Margin | 24.9% | 29.6% | 28.7% | 29.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $2 | $2 | $2 |
| Other Operating Expenses | -$0 | $0 | -$0 | -$0 |
| Operating Expenses | $2 | $2 | $2 | $2 |
| Operating Income | $1 | $1 | $0 | $1 |
| % Margin | 6.6% | 6.6% | 4.8% | 5.3% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $1 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 4% | 3.5% | 1.6% | 3.5% |
| EPS | 0.27 | 0.23 | 0.1 | 0.21 |
| % Growth | 17.4% | 130.9% | -52.6% | – |
| EPS Diluted | 0.27 | 0.23 | 0.099 | 0.21 |
| Weighted Avg Shares Out | 2 | 2 | 2 | 2 |
| Weighted Avg Shares Out Dil | 2 | 2 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $0 | -$0 |
| EBITDA | $1 | $1 | $1 | $0 |
| % Margin | 11.8% | 10.9% | 9.1% | 0.1% |